Cardio Diagnostics, a University of Iowa faculty startup, has commercially launched a new home clinical test for assessing patients’ heart disease risk. The product, the Epi+Gen CHD at-home sampling kit, was made possible through a license held by the UI Research Foundation. Heart disease and stroke are the first and fifth leading causes of death in the United States, respectively and are...

University of Iowa spinoff Cardio Diagnostics Inc., a company that assesses genetic and epigenetic DNA markers to monitor a patient's risk for heart disease, was recently selected a “one to watch” in this year’s inaugural Spinoff Prize, organized by Nature Research and Merck KGaA. The prize is intended to showcase and celebrate global excellence in the commercialization of research through the...

If a tree falls in the woods and no one is around to sees it, did it happen? And if researchers make discoveries with commercial potential but don’t protect and license their inventions, will they ever reach the market? Unlikely, says University of Iowa Research Foundation (UIRF) Executive Director Marie Kerbeshian, who is also an assistant vice president in the Office of the Vice President for...